{"protocolSection": {"identificationModule": {"nctId": "NCT02053584", "orgStudyIdInfo": {"id": "CR-0002"}, "organization": {"fullName": "LabStyle Innovations Ltd.", "class": "INDUSTRY"}, "briefTitle": "Dario\u2122 Blood Glucose Monitoring System - User Performance Evaluation", "officialTitle": "Dario\u2122 Blood Glucose Monitoring System - User Performance Evaluation"}, "statusModule": {"statusVerifiedDate": "2016-07", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2013-06"}, "primaryCompletionDateStruct": {"date": "2013-06", "type": "ACTUAL"}, "completionDateStruct": {"date": "2013-06", "type": "ACTUAL"}, "studyFirstSubmitDate": "2014-01-30", "studyFirstSubmitQcDate": "2014-01-31", "studyFirstPostDateStruct": {"date": "2014-02-03", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2014-09-08", "resultsFirstSubmitQcDate": "2021-12-19", "resultsFirstPostDateStruct": {"date": "2021-12-21", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2021-12-19", "lastUpdatePostDateStruct": {"date": "2021-12-21", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "LabStyle Innovations Ltd.", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "The study is performed to evaluate the accuracy of blood glucose level results obtained from fingertip using Labstyle Dario Blood Glucose Monitoring System (BGMS) compared to reference equipment (YSI 2300 STATPLUS) and to evaluate the ease of use of the Dario Device by the lay-person.\n\nThe participants will review the Dario user manual and guide and will be requested to operate the Dario BGMS and perform their own glucose blood test, after which they will be asked to complete a questionnaire. As reference the participants will be tested by professional caregivers both using the Dario BGMS and by YSI 2003.", "detailedDescription": "Device accuracy will be assessed based on the acceptance criteria of ISO 15197:2003 which states: \"The minimum acceptable accuracy for results produced by a glucose monitoring system shall be as follows: 95% of the individual glucose results shall fall within 15 mg/dL of the results of Reference method at glucose concentrations \u2265 4,2 mmol/L (\u2265 75 mg/dL)\"."}, "conditionsModule": {"conditions": ["Diabetes"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "NA", "interventionModel": "SINGLE_GROUP", "primaryPurpose": "OTHER", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 230, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Dario BGMS", "type": "EXPERIMENTAL", "interventionNames": ["Device: Dario\u2122 Blood Glucose Meter", "Device: YSI2003"]}], "interventions": [{"type": "DEVICE", "name": "Dario\u2122 Blood Glucose Meter", "description": "Each subject will undergo a finger prick and also provide a venous blood sample", "armGroupLabels": ["Dario BGMS"]}, {"type": "DEVICE", "name": "YSI2003", "description": "Blood samples will be tested using YSI (gold standard) for comparison to evaluate accuracy.", "armGroupLabels": ["Dario BGMS"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "BGMS Accuracy Assessment When Used by Layperson", "description": "The minimum acceptable accuracy for results produced by a glucose monitoring system shall be as follows: 95% of the individual glucose results shall fall within 15 mg/dL of the results of reference method (YSI) at glucose concentrations \u2265 4,2 mmol/L (\u2265 75 mg/dL). (ISO 15197:2003)", "timeFrame": "Within 6 seconds of applying blood drop to strip"}], "secondaryOutcomes": [{"measure": "Evaluation of the Ease of Use of the Dario BGMS by the Lay-person", "description": "Each participant receives a survey to fill in describing their usage of the device and their opinions on the ease of use.", "timeFrame": "Within a couple of hours from the time labelling material was provided to the subject"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Male or female between the age 18 and 80\n* Type 1 and Type 2 diabetes\n\nExclusion Criteria:\n\n* Drug and alcohol abuse\n* Investigator discretion", "healthyVolunteers": false, "stdAges": ["CHILD", "ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Julio Vainstein, MD", "affiliation": "Wolfson Medical Center", "role": "PRINCIPAL_INVESTIGATOR"}]}, "ipdSharingStatementModule": {"ipdSharing": "NO"}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "230 patients were consented, the patients from day one (n=68) were excluded from the final results analysis due to a number of technical issues.", "groups": [{"id": "FG000", "title": "Dario BGMS", "description": "Dario\u2122 Blood Glucose Meter: Each subject will undergo a finger prick and also provide a venous blood sample\n\nYSI2003: Blood samples will be tested using YSI (gold standard) for comparison to evaluate accuracy."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "230"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "comment": "68 subjects (day one participants) were excluded from the final analysis.", "numSubjects": "230"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Dario BGMS", "description": "Dario\u2122 Blood Glucose Meter: Each subject will undergo a finger prick and also provide a venous blood sample\n\nYSI2003: Blood samples will be tested using YSI (gold standard) for comparison to evaluate accuracy."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "161"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEDIAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "55.5", "spread": "17.6"}]}]}]}, {"title": "Age, Categorical", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "95"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "66"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "97"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "64"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "Israel", "categories": [{"measurements": [{"groupId": "BG000", "value": "161"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "BGMS Accuracy Assessment When Used by Layperson", "description": "The minimum acceptable accuracy for results produced by a glucose monitoring system shall be as follows: 95% of the individual glucose results shall fall within 15 mg/dL of the results of reference method (YSI) at glucose concentrations \u2265 4,2 mmol/L (\u2265 75 mg/dL). (ISO 15197:2003)", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage of participants", "timeFrame": "Within 6 seconds of applying blood drop to strip", "groups": [{"id": "OG000", "title": "Dario BGMS", "description": "Dario\u2122 Blood Glucose Meter: Each subject will undergo a finger prick and also provide a venous blood sample\n\nYSI2003: Blood samples will be tested using YSI (gold standard) for comparison to evaluate accuracy."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "161"}]}], "classes": [{"title": "< 75 mg/dl Within \u00b15mg/dL", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}]}]}, {"title": "< 75 mg/dl Within \u00b110mg/dL", "categories": [{"measurements": [{"groupId": "OG000", "value": "4"}]}]}, {"title": "< 75 mg/dl Within \u00b115mg/dL", "categories": [{"measurements": [{"groupId": "OG000", "value": "6"}]}]}, {"title": ">= 75 mg/dl Within \u00b15%", "categories": [{"measurements": [{"groupId": "OG000", "value": "44"}]}]}, {"title": ">= 75 mg/dl Within \u00b110%", "categories": [{"measurements": [{"groupId": "OG000", "value": "78"}]}]}, {"title": ">= 75 mg/dl Within \u00b115%", "categories": [{"measurements": [{"groupId": "OG000", "value": "126"}]}]}, {"title": ">= 75 mg/dl Within \u00b120%", "categories": [{"measurements": [{"groupId": "OG000", "value": "150"}]}]}, {"title": ">= 75 mg/dl", "categories": [{"measurements": [{"groupId": "OG000", "value": "155"}]}]}]}, {"type": "SECONDARY", "title": "Evaluation of the Ease of Use of the Dario BGMS by the Lay-person", "description": "Each participant receives a survey to fill in describing their usage of the device and their opinions on the ease of use.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "Within a couple of hours from the time labelling material was provided to the subject", "groups": [{"id": "OG000", "title": "Dario BGMS (Easily Understood)", "description": "Dario\u2122 Blood Glucose Meter: Each subject will undergo a finger prick and also provide a venous blood sample. Subjects reported that the labels were easily understood.\n\nYSI2003: Blood samples will be tested using YSI (gold standard) for comparison to evaluate accuracy."}, {"id": "OG001", "title": "Dario BGMS (Understood After Few Attempts)", "description": "Dario\u2122 Blood Glucose Meter: Each subject will undergo a finger prick and also provide a venous blood sample. Subjects reported that the labels were understood after few attempts.\n\nYSI2003: Blood samples will be tested using YSI (gold standard) for comparison to evaluate accuracy."}, {"id": "OG002", "title": "Dario BGMS (Did Not Understand How to Use)", "description": "Dario\u2122 Blood Glucose Meter: Each subject will undergo a finger prick and also provide a venous blood sample. Subjects reported that the labels were not clear and that they did not understand how to use.\n\nYSI2003: Blood samples will be tested using YSI (gold standard) for comparison to evaluate accuracy."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "161"}, {"groupId": "OG001", "value": "161"}, {"groupId": "OG002", "value": "161"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "93"}, {"groupId": "OG001", "value": "67"}, {"groupId": "OG002", "value": "1"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "eventGroups": [{"id": "EG000", "title": "Dario BGMS", "description": "Dario\u2122 Blood Glucose Meter: Each subject will undergo a finger prick and also provide a venous blood sample\n\nYSI2003: Blood samples will be tested using YSI (gold standard) for comparison to evaluate accuracy.", "seriousNumAffected": 0, "seriousNumAtRisk": 161, "otherNumAffected": 0, "otherNumAtRisk": 161}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Dr. Julio Weinstein", "organization": "Wolfson Medical Center", "email": "vainstein@wolfson.health.gov.il", "phone": "972-3-5028371"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"browseLeaves": [{"id": "M7115", "name": "Diabetes Mellitus", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC18", "name": "Nutritional and Metabolic Diseases"}, {"abbrev": "BC19", "name": "Gland and Hormone Related Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}}, "hasResults": true}